[{"Assets_0_Q3_USD":398255000.0,"CommonStockSharesOutstanding_0_Q3_shares":46955365.0,"EarningsPerShareBasic_3_Q3_USD":-0.79,"EarningsPerShareBasic_1_Q3_USD":-0.33,"EarningsPerShareDiluted_3_Q3_USD":-0.79,"EarningsPerShareDiluted_1_Q3_USD":-0.33,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-27017000.0,"NetIncomeLoss_3_Q3_USD":-37082000.0,"NetIncomeLoss_1_Q3_USD":-15562000.0,"StockholdersEquity_0_Q3_USD":290539000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":46766562.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":46929498.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":46766562.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":46929498.0,"Ticker":"XNCR","CIK":"1326732","name":"XENCOR INC","OfficialName":"Xencor Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574633486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]